Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 97,249 | 186,727 | 125,744 | 123,665 | 117,368 |
| Marketable Securities | 321,664 | 154,890 | 111,611 | 203,235 | 188,451 |
| Receivables | 165,000 | 10,000 | 10 | 1,566 | 2,426 |
| Other current assets | 0 | 0 | 0 | 2,792 | 1,084 |
| TOTAL | $591,641 | $355,577 | $243,077 | $340,736 | $315,606 |
| Non-Current Assets | |||||
| PPE Net | 3,190 | 1,195 | 1,565 | 1,798 | 1,462 |
| Investments And Advances | 140,252 | 0 | 0 | 0 | 2,000 |
| Other Non-Current Assets | 9,642 | 1,179 | 3,286 | 5,161 | 5,400 |
| TOTAL | $153,084 | $2,374 | $4,851 | $6,959 | $8,862 |
| Total Assets | $744,725 | $357,951 | $247,928 | $347,695 | $324,468 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,615 | 775 | 3,709 | 2,499 | 5,807 |
| Accrued Expenses | 23,693 | 19,358 | 24,955 | 37,716 | 18,498 |
| TOTAL | $47,398 | $21,274 | $31,179 | $44,016 | $40,241 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 18,891 | N/A | N/A | 1,601 | 14,477 |
| Other Non-Current Liabilities | 10,356 | 0 | 1,141 | 3,658 | 4,621 |
| TOTAL | $22,032 | $N/A | $1,141 | $3,658 | $4,621 |
| Total Liabilities | $69,430 | $21,274 | $32,320 | $47,674 | $44,862 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 61,384 | 58,275 | 51,275 | 48,414 | 43,808 |
| Common Shares | 1 | 1 | N/A | N/A | N/A |
| Retained earnings | -340,522 | -615,710 | -536,755 | -409,362 | -283,811 |
| Other shareholders' equity | -82 | -105 | -359 | -299 | 28 |
| TOTAL | $675,295 | $336,677 | $215,608 | $300,021 | $279,606 |
| Total Liabilities And Equity | $744,725 | $357,951 | $247,928 | $347,695 | $324,468 |